These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 35086691)

  • 1. Overcoming barriers for intra-articular delivery of disease-modifying osteoarthritis drugs.
    Gao J; Xia Z; Mary HB; Joseph J; Luo JN; Joshi N
    Trends Pharmacol Sci; 2022 Mar; 43(3):171-187. PubMed ID: 35086691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in intra-articular drug delivery systems for osteoarthritis therapy.
    Maudens P; Jordan O; Allémann E
    Drug Discov Today; 2018 Oct; 23(10):1761-1775. PubMed ID: 29792929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in intra-articular drug delivery systems for osteoarthritis.
    Yang X; Du H; Zhai G
    Curr Drug Targets; 2014; 15(9):888-900. PubMed ID: 25090987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomaterial strategies for improved intra-articular drug delivery.
    Mancipe Castro LM; García AJ; Guldberg RE
    J Biomed Mater Res A; 2021 Apr; 109(4):426-436. PubMed ID: 32780515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in targeted drug delivery for treatment of osteoarthritis.
    Mehta S; He T; Bajpayee AG
    Curr Opin Rheumatol; 2021 Jan; 33(1):94-109. PubMed ID: 33229973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-articular drug delivery systems for osteoarthritis therapy: shifting from sustained release to enhancing penetration into cartilage.
    Huang H; Lou Z; Zheng S; Wu J; Yao Q; Chen R; Kou L; Chen D
    Drug Deliv; 2022 Dec; 29(1):767-791. PubMed ID: 35261301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-surgical osteoarthritis therapy, intra-articular drug delivery towards clinical applications.
    Liang Y; Xu X; Xu L; Prasadam I; Duan L; Xiao Y; Xia J
    J Drug Target; 2021 Jul; 29(6):609-616. PubMed ID: 33356642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Models for Development of Disease-Modifying Osteoarthritis Drugs.
    Makarczyk MJ; Gao Q; He Y; Li Z; Gold MS; Hochberg MC; Bunnell BA; Tuan RS; Goodman SB; Lin H
    Tissue Eng Part C Methods; 2021 Feb; 27(2):124-138. PubMed ID: 33403944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-articular targeting of nanomaterials for the treatment of osteoarthritis.
    Brown S; Kumar S; Sharma B
    Acta Biomater; 2019 Jul; 93():239-257. PubMed ID: 30862551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date.
    Oo WM; Little C; Duong V; Hunter DJ
    Drug Des Devel Ther; 2021; 15():2921-2945. PubMed ID: 34262259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis.
    Abadie E; Ethgen D; Avouac B; Bouvenot G; Branco J; Bruyere O; Calvo G; Devogelaer JP; Dreiser RL; Herrero-Beaumont G; Kahan A; Kreutz G; Laslop A; Lemmel EM; Nuki G; Van De Putte L; Vanhaelst L; Reginster JY;
    Osteoarthritis Cartilage; 2004 Apr; 12(4):263-8. PubMed ID: 15023377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candidates for Intra-Articular Administration Therapeutics and Therapies of Osteoarthritis.
    Toyoda E; Maehara M; Watanabe M; Sato M
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocrystal-chitosan particles for intra-articular delivery of disease-modifying osteoarthritis drugs.
    Morici L; Gonzalez-Fernandez P; Jenni S; Porcello A; Allémann E; Jordan O; Rodríguez-Nogales C
    Int J Pharm; 2024 Feb; 651():123754. PubMed ID: 38163526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant protein drugs-based intra articular drug delivery systems for osteoarthritis therapy.
    Huang H; Lin Y; Jiang Y; Yao Q; Chen R; Zhao YZ; Kou L
    Eur J Pharm Biopharm; 2023 Feb; 183():33-46. PubMed ID: 36563886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of hydrogel-based intra-articular drug delivery for the treatment of osteoarthritis.
    He Z; Wang B; Hu C; Zhao J
    Colloids Surf B Biointerfaces; 2017 Jun; 154():33-39. PubMed ID: 28288340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research progress of nanomaterials for intra-articular targeted drug delivery in treatment of osteoarthritis].
    Zong L; Wu Q; Dong Z; Huang L; Yang H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2022 Jul; 36(7):908-914. PubMed ID: 35848190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects of Disease-Modifying Osteoarthritis Drugs.
    Oo WM
    Clin Geriatr Med; 2022 May; 38(2):397-432. PubMed ID: 35410687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating intra-articular drug delivery for the treatment of osteoarthritis in a rat model.
    Allen KD; Adams SB; Setton LA
    Tissue Eng Part B Rev; 2010 Feb; 16(1):81-92. PubMed ID: 19943805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics, efficacy, safety and administration of intra-articular therapies for knee osteoarthritis.
    Oo WM; Liu X; Hunter DJ
    Expert Opin Drug Metab Toxicol; 2019 Dec; 15(12):1021-1032. PubMed ID: 31709838
    [No Abstract]   [Full Text] [Related]  

  • 20. Polymer particles for the intra-articular delivery of drugs to treat osteoarthritis.
    Mei X; Villamagna IJ; Nguyen T; Beier F; Appleton CT; Gillies ER
    Biomed Mater; 2021 Apr; 16(4):. PubMed ID: 33711838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.